Cover
Vol. 3 No. 2 (2013)

Published: December 31, 2013

Pages: 26-31

Research Article

In vitro sperm activation with pentoxifylline and L-carnitine for infertile men semen using layering and sedimentation techniques

Abstract

ackground: Pretreatment of semen samples of the infertile patients and in vitro preparation techniques with the certain sperm stimulant agents prior to use for assisted reproductive techniques (ART) has been reported to have beneficial effects on pregnancy rates. Objectives: The objective of this study is to improve certain sperm function parameters in vitro of infertile patients semen by using novel combination motility stimulants substances that improved medium to be used for ART in future. Patients and Methods: One hundred infertile men involved in the current study. They were divided into four groups. Each semen sample was divided into four portions. One part was considered as a control and in vitro activated by using culture medium only. The other three portions were considered as treated groups and activated in vitro by adding pentoxifylline(PX,1mg/ml) and/or L-carnitine (LC,0.5mg/ml) to the culture media. Certain sperm function parameters were examined before and following in vitro activation using layering and sedimentation techniques. Results: The results showed a highly significant (P<0.001) improvement in the sperm concentration and percentage of progressive sperm motility grade(A), grade (B) and grade (A+B) with a highly significant (P<0.001) increase in the percentage of morphologically normal sperm (MNS) after addition of PX and/or LC to the culture medium in comparison with control medium using layering and sedimentation(layering under paraffin) techniques in the infertile patients. Conclusion: The results of this study indicate that adding 20%PXand/ or LC to the culture medium for in vitro sperm activation using layering and sedimentation techniques leads to an improvement in certain sperm function parameters.

References

  1. Suneet M, Lakhbir D, Sanjeev S, Sanjay C. Infertility. Obstetrics and Gynecology Vol,2011 Article. ID.508276.2 pages.
  2. Boivin J, Bunting L, Collins JA, Nygren KG. Intemational estimates of infertility prevalence and treatment seeking: potential need and demand for infertility medical care. Hum Reprod, 2009; 24: 23792380-.
  3. American Urological Association, Inc. (AUA). The Optimal Evaluation of the Infertile Male. AUA Best Practice Statement. Published April 2001. Revised 2010. Accessed May 13, 2010. Available at URL address: http://www.auanet.org/guidelines.
  4. Francavilla F, Sciarretta F, Sorgentone S, Necozione S, Santucci R, Barbonetti A, Francavilla S. Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial. Fertil Steril, 2009; 92(3):100911-.
  5. Lambardo F, Gandini L, Lenzi A, Dondero F. Antisperm immunity in assisted reproduction. J Reprod Immunol, 2004; 62: 101109-.
  6. Dohle GR, Jungwirth A, Colpi G, Diemer T. Guide line on male infertility. Eur Associat Urol, 2007; 11: 8-21.
  7. Karpuz V, Gokturk A, Koyuturk M. The effect of sperm morphology and motility on the Outcome of intracytoplasmic sperm injection. Marmara Med J.2007: 20:92-97
  8. Isidori AM, Pozza C, Gianfrilli D. Isidori A. Medical treatment to improve sperm quality. Reprod Biomed Online, 2006; 12: 704714-.
  9. Edwards RG, Fishel SG, Cohen J, Fehilly CB, Purdy JM, Steptoe PС, Webster JM. Factors influencing the success of in vitro fertilization for alleviating human infertility. J IVF-ET, 1984; 1: 323-.
  10. Twigg J, Irvine DS, Houston P, Fulton N, Michael L, Aitken RJ latrogenic DNA damage induced in human spermatozoa during sperm preparation: protective significance of seminal plasma. Mol Hum Reprod, 1998; 4: 439445-.
  11. Aviad DM, Dettelbache HR. Pharmacology of Pentoxifylline a heamorheologic agent for the treatment of intermittent claudication. Angiol, 1984; 35: 407-417.
  12. Stanic P, Sonicki Z, Suchanek E. Effect of pentoxifylline on motility and membrane integrity of cryopreservation human spermatozoa. International J Androl, 2002; 25:186-190.
  13. Okada H, Tatsumi N, Kanzaki M. Formation of reaction oxygen species by spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urology,1997; 157:2140-2146.
  14. SteiberA, Kerner J, Hoppelm C. Camitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med, 2004; 25 (5-455: (673
  15. Matalliotakis I, Koumantaki Y, Evageliou A. L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int J Fertil Womens, 2000; 45: 236-240.
  16. Abdel-razik H, Sharma R, Mahfouz R, Agarwal A. L-Camitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos. Fert Steri 91, Issue,2009; 2: 589596-
  17. World Health Organization (WHO).WHO laboratory Manual for the examination of human semen and semen-cervical mucus interaction. 4th ed. New York. Cambridge University Press UK, 1999: 459-.
  18. Hall J, Fishel S, Green S, Fleming S, Hunter A, Stoddert N, Dowell K, Thornton S. Intracytoplasmic sperm injection versus high insemination concentration in vitro fertilization in cases of very severe teratozoospermia. Hum Reprod, 1995;10: 4936-.
  19. Sorlie DE. Examination and board review: Medical Biostatistics and Epidemiology. (1st ed.). Appleton and Lang Norwalk Connecticut, 1995:4788-.
  20. Sharma RK, Said T, Agarwal A. Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian J Androl, 2004; 6: 13948-.
  21. Al-Dujaily SS, Malik K. In vitro sperm activation for asthenospermic semen by using progesterone, pentoxifylline and Glycyrrhiza glabra extraction.Globel. J Med Res, 2013; 3(1): 16-.
  22. Al-Dujaily SS, AL-Janabi AS, Nori M. Effect of Glycyrrhiza extract on in vitro sperm activation of asthenospermic patients. J Babylon University, 2006; 11: 477483-.
  23. Abid RS. Effect of pentoxifylline (Trental®)on human sperm in vitro activation of asthenospermic infertile patients. High diploma thesis Institute of Embryo Research on Infertility Treatment Al- Nahrian University, 2005.
  24. Al-Dujaily SS, Al-Nakash AR, Al-Biaty SA. Effect of pentoxifylline on the outcome of artificial inseminations. Iraqi post graduate. Med J 2007; 5: 377383-.
  25. Sato M, Ishikawa A. Room temperature storage of mouse epididymal spermatozoa: exploration of factors affecting sperm survival. Theriogenology, 2004; 61(769-1455:(8-.
  26. Al-Dujaily SS, Al-Shahiri N, Abbas A. Effect of L-carnitine on in vitro sperm activation of infertile men. IJ Embryo inter Res, 2012; 2(3): 2225-.
  27. Peivandi S, Karimpour A, Moslemizadeh N. Effects of L-camitine on Infertie Men's Spermogram, a Randomized Clinical Trial. J Reprod Infertil, 2010; 10(4):331.
  28. Agarwal A, Said TM. Carnitine and male infertility. Reprod Biomed 2004: 8:376384-.
  29. Berni A, Meschini R, Filippi S. Palitti F, De Amicis A, Chessa L. L-carnitine enhances resistance to oxidative stress by reducing DNA damage in Ataxia telangiectasia cells. Mutat Res, 2008: 650: 16574-.
  30. Aliabadi E, Karimi F, Rasti M, Akmali M, Esmaeilpour T. Effects of I-carnitine and pentoxifylline on the activity of lactate dehydrogenase C4 isozyme and motility of testicular spermatozoa in mice. J Reprod Infertil, 2013; 14(2): 5661-.
  31. Menezo YJ, Hazout A, Panteix G, Robert F, Rollet J, Cohen-Bacrie P. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reprod Biomed Online, 2007; 14: 418421-
  32. Sanchez R, Stalf T, Khanaga O. Sperm selection methods for intracytoplasmic sperm injection (ICSI) and andrological patients. J Androl, 1996; 13: 228233-.
  33. Henkel R, Schill W. Sperm preparation for ART. Reprod Biol Endocr, 2003; 1: 108115-99:6.120-.